Pharmacy Error Injury Lawyer Blog

Why a Maryland Pharmacy’s Error Records Stay Out of a Lawsuit

October 28, 2026 | Lebowitz & Mzhen

Pharmacists are now arguing in their own professional journal that dispensing errors at outpatient pharmacies need better data and more transparency. A commentary published online September 22, 2026, in the Journal of the American Pharmacists Association describes a policy adopted by the American Public Health Association. The policy treats dispensing safety as a public health issue. Its three parts are improved data collection and transparency, a stronger culture of safety, and enhanced external accountability.

Maryland’s pharmacy error reporting rules are internal. Every pharmacy must investigate and record each medication error, and the same regulation keeps that record out of civil cases. A Maryland pharmacy error claim therefore has to be proved with other evidence.

That evidence exists, and much of it starts in the patient’s hands. Lebowitz & Mzhen Personal Injury Lawyers handles Maryland pharmacy error claims, which are built from the bottle, the label, the prescription, and the patient’s medical records.

How a Hospital Pharmacy Put the Wrong Drug in a Spinal Injection

September 29, 2026 | Lebowitz & Mzhen

Last updated September 29, 2026 · Reviewed by Vadim A. Mzhen

Four patients having elective joint replacement surgery at a Nashville hospital on August 14, 2026, were injected in the spine with potassium phosphate instead of the anesthetic that had been ordered for them. All four had to be transferred to a higher level of care, and one briefly went into cardiac arrest. Becker’s Hospital Review reported on August 28 that a state survey traced the error to the hospital’s own pharmacy and placed the hospital in immediate jeopardy on three federal conditions of participation.

In Maryland, an injury caused by a hospital pharmacy error is a claim against the hospital, which state law counts as a health care provider. Claims like that do not start in circuit court. They begin with a filing in the Health Care Alternative Dispute Resolution Office, and they run on the medical malpractice deadline rather than the ordinary three-year personal injury period.

When a Compounded Injection Is Recalled for Contamination

August 31, 2026 | Lebowitz & Mzhen

Last updated August 21, 2026 · Reviewed by Jack D. Lebowitz

Two compounded glutathione products were pulled from the market in August 2026, both over elevated bacterial endotoxin levels in multi-dose vials. One pharmacy recalled three lots on August 5, and a second recalled a lot on August 19, both announced through the FDA. Neither was a labeling mistake or the wrong drug in the wrong bottle. The recalled product was the drug it claimed to be, and it was unsafe anyway.

That distinction carries real legal weight. A contamination case does not depend on proving that a pharmacist grabbed the wrong shelf; it depends on proving that a sterile product left the facility in a condition it should never have been in. Patients who received an injection and then had a reaction often never learn a recall was issued at all, because the notice goes to the clinic or the distributor rather than to them.

Injuries traced to a compounded product rather than to a dispensing mistake still fall within pharmacy misfill and medication error claims, which Lebowitz & Mzhen Personal Injury Lawyers brings for patients across Maryland.

Mislabeled Weight-Loss Drugs on Pharmacy Shelves

July 30, 2026 | Lebowitz & Mzhen

Last updated July 13, 2026 · Reviewed by the attorneys at Lebowitz & Mzhen

The popularity of GLP-1 weight-loss injections has created enormous demand, and where demand outruns supply, compounding pharmacies have stepped in. Some of them have not kept up with basic safety. As MedShadow reported, the FDA cited compounding pharmacies in 2026 for producing compounded semaglutide and tirzepatide that lacked essential labeling, including the drug’s strength, dose, and instructions for use, and in one case for failing to report a patient’s hospitalization. Around the same period, Lupin recalled a batch of liraglutide after particulate matter, a white thread-like structure, was found in the cartridge. For patients injecting these drugs at home, errors like these are not abstract.

What Goes Wrong When a Label Is Incomplete

Mislabeled Compounded Semaglutide and the Dosing Errors Putting Patients at Risk

June 29, 2026 | Lebowitz & Mzhen

The boom in weight-loss and diabetes drugs like semaglutide and tirzepatide has pushed many patients toward compounded versions, often cheaper and easier to get than the brand-name injections. That demand has also exposed serious problems in how some compounding pharmacies prepare and label these medications. Federal regulators have cited compounding pharmacies for sending out compounded GLP-1 injections that lacked basic labeling, including the strength, the dose, and instructions for how to administer the drug. In at least one case described by regulators, a patient was hospitalized for several nights after taking a compounded semaglutide injection.

How a Missing Label Becomes an Overdose

These drugs are measured in small amounts, and the gap between a correct dose and a harmful one can come down to a few units on a syringe. When a vial arrives without a clear strength or dosing instruction, a patient drawing up their own injection is left guessing. Pull too much, and the result can be severe nausea, vomiting, dehydration, dangerously low blood sugar, and the kind of gastrointestinal distress that lands people in the emergency room. A pharmacy’s labeling carries real weight. It is the instruction set a patient relies on every time they prepare a dose, and a missing or wrong label invites exactly the kind of error that injures people.

When Pharmacy and Compounding Errors Lead to Liability

Pharmacies have a duty to dispense medications accurately and to label them so patients can use them safely. When a compounding pharmacy mislabels a drug, prepares the wrong concentration, or fails to provide dosing instructions, and a patient is hurt as a result, that failure can support a claim for the harm it caused. The same holds for more familiar pharmacy mistakes, such as dispensing the wrong drug, the wrong strength, or the wrong directions on the bottle. Proving these cases depends on evidence, so patients who suspect a medication error should hold on to what they have:

When a Medication Vial Is Labeled as the Wrong Drug

May 28, 2026 | Lebowitz & Mzhen

You trust the label on your medication. What happens when that label is wrong, and you only find out after a frightening reaction?

There is a particular kind of medication error that should never happen, and yet it does. Not a wrong dose. Not a missed interaction. The label on the container says one drug, and the container actually holds another. The safeguard you and your doctor rely on most — the words printed on the package — is the very thing that misleads you.

That danger came back into focus recently when a drug manufacturer expanded a nationwide recall after vials of an antibiotic were found incorrectly labeled as a completely different medication. The complaint that triggered it was exactly what every patient and clinician fears: vials labeled as one drug were discovered inside cartons of another. For many patients, a swap like that might be caught in time. But if you have a known allergy to the drug the vial was mistakenly labeled as — or to the drug that was actually inside — that mistake can be life-threatening before anyone realizes what went wrong.

Think about how much trust you place in your medication every day. You assume the label is true. Your nurse, your pharmacist, and your doctor assume the same. If you have a serious allergy, you have probably told every medical provider about it, again and again. The whole system depends on accurate labeling. When a vial lies about its own contents, a careful nurse or pharmacist following every rule can still give you exactly the medication that puts you at risk of a severe reaction.

How Pharmacy Understaffing Turns Into a Maryland Misfill Lawsuit

April 30, 2026 | Lebowitz & Mzhen

A pharmacy misfill is the kind of injury most people do not expect to happen to them, until it does. The wrong drug. The wrong dose. The right drug for someone else, in a bottle with the patient’s own name on the label. By the time the error is caught, the harm is often already underway.

Patients tend to assume the cause was one rushed pharmacist on one bad day. The reality, increasingly, is something much bigger.

Recent reporting in The American Prospect (March 19, 2026) describes understaffing in chain pharmacies as endemic, and links it directly to a long-running pattern of dispensing errors. A January 2026 Pharmacy Times analysis based on a profession-wide burnout survey reported that pharmacists rated their burnout, on average, at 5.89 out of 7, and pointed to workload, performance metrics, and high prescription volumes as leading causes. A January 2026 Frontiers in Public Health article framed pharmacist burnout as a system-accountability problem rather than a personal coping problem. ShiftRx and other workforce reports from early 2026 connect chronic pharmacy understaffing to medication errors, abandoned counseling, and patient safety risks.

Counterfeit Ozempic and the Safety Duties Pharmacies Cannot Ignore

March 28, 2026 | Lebowitz & Mzhen

In December 2025, FDA warned that counterfeit Ozempic injection 1 mg had been found in the legitimate U.S. drug supply chain. FDA said it was notified by Novo Nordisk in November 2025, that the agency’s investigation was ongoing, and that retail pharmacies, wholesalers, health care professionals, and patients should closely inspect products for signs of counterfeit labeling. FDA also warned that counterfeit needles associated with the product raised sterility concerns, creating the possibility of infection.

That is an important pharmacy-error story because it shifts attention to a form of medication danger that patients do not always think about. Many people hear “pharmacy mistake” and think of the wrong bottle or the wrong instructions. Those cases matter, but medication safety failures can also involve sourcing, verification, packaging review, and the breakdown of safeguards that are supposed to stop suspect products before they reach a patient.

This issue is especially significant because Ozempic is a widely recognized medication, and a patient receiving a counterfeit version may have no obvious reason to doubt what they were handed. FDA’s broader guidance on counterfeit medicine explains that counterfeit drugs may contain the wrong ingredients, too much or too little active ingredient, no active ingredient at all, or other harmful ingredients.

Pharmacy Misfill Lawsuit in Maryland: What You Need to Know

February 24, 2026 | Lebowitz & Mzhen

A pharmacy misfill lawsuit in Maryland allows a patient who received the wrong medication — or the wrong dosage of the correct medication — to seek compensation for injuries caused by the pharmacist’s error. These claims fall under Maryland’s medical malpractice framework and must be filed within the deadlines set by Md. Code, Cts. & Jud. Proc. § 5-109, which generally requires that a claim be brought within five years of the injury or three years from the date the injury was discovered, whichever is earlier.

Pharmacy errors happen far more often than most patients realize. The U.S. Food and Drug Administration reports that medication errors contribute to at least one death every day nationwide. Maryland patients harmed by a prescription mistake may benefit from speaking with a pharmacy misfill attorney who understands both the medical and legal complexities of these cases. Lebowitz & Mzhen Personal Injury Lawyers handles pharmacy error claims throughout Maryland, including in Baltimore, Montgomery County, Prince George’s County, and the surrounding communities.

What Is a Pharmacy Misfill?

Prescribing Error Linked To Newborn Death After Wrong Drug Selected

January 31, 2026 | Lebowitz & Mzhen

A medication mistake in a hospital can feel unthinkable, especially in a neonatal unit where every dose is tiny and every change matters. A recent report from London described a newborn who died after a prescribing error, where a doctor selected the wrong medication from a drop-down menu and the baby received an overdose. This did not happen in Maryland, Washington, D.C., or Virginia, yet Maryland families can still take something important from it: errors can start with one click, and the aftermath often involves confusing explanations, shifting paperwork, and unanswered questions.

The hardest part for many families is not only the loss. It is the feeling that the system moves forward while you sit with a thousand details you never got to understand. Knowing how these incidents usually get reviewed, and what information tends to matter, can help you feel less stuck.

What The Report Described About The Hospital Error